ATOS
Atossa Therapeutics Inc.
Company Overview
| Mkt Cap | $109.63M | Price | $0.89 |
| Volume | 444.51K | Change | +1.09% |
| P/E Ratio | -4.3 | Open | $0.87 |
| Revenue | -- | Prev Close | $0.88 |
| Net Income | $-25.5M | 52W Range | $0.55 - $1.66 |
| Div Yield | N/A | Target | $5.69 |
| Overall | 39 | Value | 60 |
| Quality | -- | Technical | 18 |
No chart data available
Stock Overview
Updated DailyAtossa Therapeutics Inc. (ATOS) is a leading Healthcare company in the Diagnostics & Research industry, currently trading at $0.89 with a market capitalization of $109.63 million. The stock is in the lower portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows ATOS with a volume of 445K shares. The stock opened down 0.80% from yesterday's close of $0.88. Current analyst estimates project earnings of $-0.25 per share for this year, with next year targeting $-0.28.
ATOS demonstrates concerning technical signals based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including JNJ, LH, NEO, ENZ, DGX.
Key investment considerations for ATOS include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 539.6%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 06:56 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ATOS | $0.89 | +1.1% | 444.51K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Atossa Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW